Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
De Rose
Anthony J. De Rose, Rochester, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20110269053 | SOLID OXIDE FUEL CELL HAVING A GLASS COMPOSITE SEAL - A solid oxide fuel cell stack having a plurality of cassettes and a glass composite seal disposed between the sealing surfaces of adjacent cassettes, thereby joining the cassettes and providing a hermetic seal therebetween. The glass composite seal includes an alkaline earth aluminosilicate (AEAS) glass disposed about a viscous glass such that the AEAS glass retains the viscous glass in a predetermined position between the first and second sealing surfaces. The AEAS glass provides geometric stability to the glass composite seal to maintain the proper distance between the adjacent cassettes while the viscous glass provides for a compliant and self-healing seal. The glass composite seal may include fibers, powders, and/or beads of zirconium oxide, aluminum oxide, yttria-stabilized zirconia (YSZ), or mixtures thereof, to enhance the desirable properties of the glass composite seal. | 11-03-2011 |
Richard De Rose, Raleigh, NC US
| Patent application number | Description | Published |
|---|---|---|
| 20090178161 | METHOD FOR DIRECTING NUCLEIC ACIDS TO PLASTIDS - The invention relates to nucleic acid sequences naturally imported into a plant cell plastid, and use thereof for directing an RNA sequence of interest to a plastid, which permits, in particular, the directed expression of a protein of interest in a plant cell plastid. | 07-09-2009 |
Robert De Rose, Victoria AU
| Patent application number | Description | Published |
|---|---|---|
| 20110008417 | IMMUNOMODULATING COMPOSITIONS AND USES THEREFOR - This invention discloses compositions that consist essentially of a Gag polypeptide or at least one portion thereof, and optionally antigen-presenting cells or their precursors, for treating or preventing lentiviral infections including the treatment or prevention of related acquired immunodeficiency diseases. In certain embodiments, the compositions consist essentially of a plurality of overlapping and/or non-overlapping peptides derived from a single Gag polypeptide or from different Gag polypeptides. | 01-13-2011 |